Call for Papers  

Article Details


Review Article

12-Lipoxygenase: Classification, Possible Therapeutic Benefits from Inhibition, and Inhibitors

[ Vol. 6 , Issue. 5 ]

Author(s):

L. A. Dailey and P. Imming   Pages 389 - 398 ( 10 )

Abstract:


The metabolism of arachidonic acid can be catalyzed by either one of two enzyme families; the cyclooxygenases or the lipoxygenases. The family of lipoxygenases is divided into four subtypes according to tissue distribution; 5-, 8-, 12-, and 15-lipoxygenase. 12- lipoxygenase metabolites, such as 12(8)-hydroxyeicosatetraenoic acid, have been found to play a central role in the various stages of the metastatic process in tumors and are, therefore, potential targets for anticancer treatment. A variety of lipoxygenase inhibitors already exist and can be classified into five major categories according to their mechanism of inhibition. These include antioxidants, iron chelators, substrate analogues, lipoxygenase-activating protein inhibitors, and, finally, epidermal growth factor-receptor inhibitors.

Keywords:

Affiliation:



Read Full-Text article